| 冯博,徐玮,郑嵘,田勇.普米克令舒联合博利康尼对重型颅脑损伤患者气管切开后肺部感染的疗效观察[J].浙江中西医结合杂志,2015,25(5): |
| 普米克令舒联合博利康尼对重型颅脑损伤患者气管切开后肺部感染的疗效观察 |
| Curative effect observation of Pulmicort Respules,Terbutaline atomization inhalation in the treatment of severe traumatic brain injury patients with pulmonary infectionFENG Bo,XU Wei,ZHENG Rong,et al. |
| 投稿时间：2014-12-13 修订日期：2014-12-26 |
| DOI： |
| 中文关键词: 普米克令舒 博利康尼 重型颅脑损伤 肺部感染 气管切开 |
| 英文关键词:Pulmicort Respules Terbutaline severe traumatic brain injury pulmonary infection Tracheotomy |
| 基金项目: |
|
| 摘要点击次数: 722 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的 观察普米克令舒联合博利康尼雾化吸入治疗重型颅脑损伤患者气管切开后并发肺部感染的临床疗效。方法 将64例重型颅脑损伤气管切开后并发肺部感染患者随机分为治疗组和对照组各32例。在常规治疗基础上对照组辅以生理盐水 ??-糜蛋白酶雾化吸入；治疗组在对照组基础上加用普米克令舒联合博利康尼雾化吸入。比较两组患者治疗后血常规、超敏C反应蛋白、症状体征改善时间及疗效。结果 治疗组总有效率高于对照组,观察指标改善时间短于对照组,差异有统计学意义(P<0.05)。结论 普米克令舒联合博利康尼雾化吸入治疗重型颅脑损伤患者气管切开后并发肺部感染的临床疗效显著,患者依从性好,值得临床推广。 |
| 英文摘要: |
| Objective Observation on Pulmicort Bricanyl inhalation combined with clinical efficacy in the treatment of severe traumatic brain injury patients with pulmonary infection after tracheotomy. Methods 64 cases of severe traumatic brain injury after tracheotomy in patients with pulmonary infection were randomly divided into treatment group and control group with 32 cases in each group. The control group with normal saline ??-chymotrypsin atomizing inhalation on the basis of conventional treatment;treatment group in the control group based on the use of Pulmicort Respules combined with Bricanyl nebulized inhalation. Comparison of two groups of patients after treatment, blood routine, high sensitive C reactive protein,signs and symptoms improved time and curative effect.Result The total effective rate of treatment group was higher than the control group,the observation index improved time was shorter than the control group, the difference was statistically significant (P<0.05).Conclusion Pulmicort Bricanyl nebulising inhalation combined with significant clinical efficacy in treatment of severe traumatic brain injury patients after tracheotomy complicated with pulmonary infection, patient compliance is good, is worth the clinical promotion. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
